Page last updated: 2024-08-22

camptothecin and Neoplasms, Squamous Cell

camptothecin has been researched along with Neoplasms, Squamous Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatayama, S; Honda, T; Kagabu, M; Kaido, Y; Kumagai, S; Miura, F; Morohara, Y; Murai, M; Omi, H; Satoh, A; Shoji, T; Sugiyama, T; Takatori, E; Yoshizaki, A1
Bains, M; Campbell, J; Capanu, M; Ilson, DH; Kelsen, DP; Ku, GY; Minsky, BD; Rizk, N; Rusch, V; Shah, M; Tang, L1
Iwai, T; Kawano, T; Miyake, S; Nagai, K; Nakajima, Y1

Trials

1 trial(s) available for camptothecin and Neoplasms, Squamous Cell

ArticleYear
Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer.
    Cancer, 2012, Jun-01, Volume: 118, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Induction Chemotherapy; Irinotecan; Male; Middle Aged; Neoplasms, Squamous Cell; Positron-Emission Tomography

2012

Other Studies

2 other study(ies) available for camptothecin and Neoplasms, Squamous Cell

ArticleYear
[Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease Progression; Female; Humans; Irinotecan; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Squamous Cell; Survival Rate; Uterine Cervical Neoplasms

2010
CPT-11 may provide therapeutic efficacy for esophageal squamous cell cancer and the effects correlate with the level of DNA topoisomerase I protein.
    Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:12

    Topics: Blotting, Western; Camptothecin; Cell Division; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Esophageal Neoplasms; Humans; Irinotecan; Neoplasms, Squamous Cell; RNA, Messenger; Tumor Cells, Cultured

2001